SEATTLE--(BUSINESS WIRE)-- Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10 ...

Know Labs’ first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor’s accuracy and medical application. SEATTLE--(BUSINESS WIRE) ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy ...

SEATTLE--(BUSINESS WIRE)-- Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment ...

Company to Drive Monetization of its Patented Platform Technology Across Diverse Industries The launch of KTL represents a pivotal milestone in Know Labs’ strategic growth plan. While the company ...

SEATTLE--(BUSINESS WIRE)-- Know Labs, Inc. (KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today a 1 for 40 reverse stock ...

Know Labs has put forward additional proof-of-concept data from its needle-free blood sugar monitor, designed to continuously scan the blood through a person’s skin. The company said its digital, ...

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, through its patented and patent pending electromagnetic energy technology platforms, announced today that it ...

Know Labs, Inc. (NYSE American: KNW) (“Know Labs”or the “Company”), a technology innovator specializing in non-invasive health monitoring solutions, today issued a reminder to its stockholders to vote ...